Phillip Grant Garrison

Dr. Phillip Grant Garrison

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in JACC: Case Reports
Verified
Journal Article
Open access
PGPhillip Grant Garrison
Phillip Grant Garrison
LELauren East
Lauren East
CWCharles Wanna
Charles Wanna
BPBishow Paudel
Bishow Paudel
JTJose Tallaj
Jose Tallaj
SCStephen Clarkson
Stephen Clarkson
Although exceedingly rare, pheochromocytomas can present with heart failure and cardiogenic shock, leading to complex management considerations. A 49-year-old woman presented with chest pain and palpitations, and ultimately developed cardiogenic shock secondary to a pheochromocytoma. She required Impella 5.5 preceded by Impella CP (Abiomed) and venoarterial extracorporeal membrane oxygenation support as a bridge to surgical resection. After adrenalectomy, she was weaned from mechanical circulatory support, with recovery of left ventricular function. Pheochromocytomas are rare catecholamine-secreting tumors. Patients typically present with episodic headache, sweating, and tachycardia; however, pheochromocytomas can be associated with cardiomyopathy secondary to the catecholamine excess. Mechanical circulatory support can serve as a safe and effective approach to stabilize patients while awaiting tumor resection. Mechanical circulatory support is a valuable adjunct in managing refractory heart failure by providing temporary hemodynamic stabilization while awaiting tumor resection. Ejection fraction can recover after removal of catecholamine-induced myocardial injury.

11 June 2025 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
PGPhillip Grant Garrison
Phillip Grant Garrison
JRJulie Roy
Julie Roy
MHMax Habicht
Max Habicht
SBSarah Battle
Sarah Battle
HWHana Winders
Hana Winders
PBPamela Bailey
Pamela Bailey
Background: Rising rates of opioid use disorder (OUD), usually via injection, has resulted in younger patients being diagnosed with infective endocarditis (IE), with unique treatment challenges. Methods: This retrospective ecological study analyzed hospital discharge and home health records from 2016 to 2022 in South Carolina (SC). Cases of IE with concurrent coding for OUD were identified. Differences in patient demographics, hospital characteristics, length of care days, and charges by OUD status were determined using chi-square or t-tests. IE hospitalization rates by OUD status, year, and age group were calculated, and linear regression was used to determine differences by year. Results: There were 8601 acute-care hospitalization records for IE from 2016 to 2022 in the SC dataset, of which 1180 (13.7%) had concurrent OUD coding. Statistically significant differences between patients with and without OUD were identified for sex, age group, race, resident rurality, average number of comorbidities, disposition status, and year (all p < 0.01). The incidence rate of IE increased from 2.5/100,000 in 2016 to 6.9/100,000 in 2022 in patients aged 36 to 49 years with OUD (p = 0.02). Patients with IE and OUD who were discharged home had significantly longer lengths of stay in acute care hospitals (32.9 vs. 15.3 days; p < 0.01) and excessive hospital charges ($308,874 vs. $188,862) compared to those without OUD. Conclusions: Major changes have occurred in the demographics of IE in SC. The increasing incidence rate of IE in younger adults with OUD coupled with prolonged stays at acute care hospitals pose challenges to the healthcare system that require creative solutions.